|
Originally published In Press as doi:10.1074/jbc.M102767200 on May 23, 2001
J. Biol. Chem., Vol. 276, Issue 30, 28413-28420, July 27, 2001
Folding Requirements Are Different between Sterol
14 -Demethylase (CYP51) from Mycobacterium
tuberculosis and Human or Fungal Orthologs*
Galina I.
Lepesheva ,
Larissa M.
Podust,
Aouatef
Bellamine, and
Michael R.
Waterman§
From the Department of Biochemistry, Vanderbilt University School
of Medicine, Nashville, Tennessee 37232-0146
Upon sequence alignment of CYP51 sterol
14 -demethylase from animals, plants, fungi, and bacteria, arginine
corresponding to Arg-448 of CYP51 in Mycobacterium
tuberculosis (MT) is conserved near the C terminus of all family
members. In MTCYP51 Arg-448 forms a salt bridge with Asp-287,
connecting -strand 3-2 with helix J. Deletion of the three
C-terminal residues of MTCYP51 has little effect on expression of P450
in Escherichia coli. However, truncation of the fourth
amino acid (Arg-448) completely abolishes P450 expression. We have
investigated whether Arg-448 has other structural or functional roles
in addition to folding and whether its conservation reflects
conservation of a common folding pathway in the CYP51 family.
Characterization of wild type protein and three mutants, R448K, R448I,
and R448A, including examination of catalytic activity, secondary and
tertiary structure analysis by circular dichroism and tryptophan
fluorescence, and studies of both equilibrium and temporal MTCYP51
unfolding behavior, shows that Arg-448 does not play any role in P450
function or maintenance of the native structure. C-terminal truncation
of Candida albicans and human CYP51 orthologs reveals that,
despite conservation in sequence, the requirement for arginine at the
homologous C-terminal position in folding in E. coli is not
conserved. Thus, despite similar spatial folds, functionally related
but evolutionarily distinct P450s can follow different folding pathways.
*
This work was supported by Grants GM37942 and ES00267-32
from the National Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Permanent address: Inst. of Bioorganic Chemistry, National Academy
of Sciences of Belarus, Minsk, 220141, Belarus. Tel.: 172-637274; E-mail: lepesh@ns.iboch.ac.by.
§
To whom the correspondence should be addressed: Dept. of
Biochemistry, Vanderbilt University School of Medicine, Nashville, TN
37232-0146. Tel.: 615-322-3318; Fax: 615-322-4349; E-mail: michael.waterman@mcmail.vanderbilt.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. I. Lepesheva, N. G. Zaitseva, W. D. Nes, W. Zhou, M. Arase, J. Liu, G. C. Hill, and M. R. Waterman
CYP51 from Trypanosoma cruzi: A PHYLA-SPECIFIC RESIDUE IN THE B' HELIX DEFINES SUBSTRATE PREFERENCES OF STEROL 14{alpha}-DEMETHYLASE
J. Biol. Chem.,
February 10, 2006;
281(6):
3577 - 3585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bellamine, G. I. Lepesheva, and M. R. Waterman
Fluconazole binding and sterol demethylation in three CYP51 isoforms indicate differences in active site topology
J. Lipid Res.,
November 1, 2004;
45(11):
2000 - 2007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. McLean, K. R. Marshall, A. Richmond, I. S. Hunter, K. Fowler, T. Kieser, S. S. Gurcha, G. S. Besra, and A. W. Munro
Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes
Microbiology,
October 1, 2002;
148(10):
2937 - 2949.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|